Finding:

1. close

   Angela Hartley Brodie

   She works in the University of Maryland Greenebaum Cancer Center's Hormone Responsive Cancers research program. ... Angela Brodie - Awards
2. close

   University of Maryland Greenebaum Cancer Center

   For example, many patients in the landmark studies of MOPP treatment for Hodgkin’s disease were treated at the BCRC. ... UM Professor of pharmacology Angela H. Brodie, Ph.D., [] pioneered the development of a new class of breast cancer drugs, aromatase inhibitors, now the standard of care for women worldwide.
3. close

   Worcester Foundation for Biomedical Research

   In the 1970s, WFEB scientists undertook the first systematic study of anti-tumor effects of the anti-estrogen tamoxifen led by 2003 Kettering Prize recipient V. Craig Jordan and initial studies of aromatase inhibitors by 2005 Kettering prize recipient Angela Brodie, two important classes of drugs to treat breast cancer.
4. close

   Tuberculosis treatment

   ↑ Angela Quintal. ... ↑ Brodie MJ, Boobis AR, Hillyard CJ, Abeyasekera G, MacIntyre I, Park BK (1981).
5. close

   Kettering Prize

   The Kettering Prize is given for the most outstanding recent contribution to the diagnosis or treatment of cancer. ... 2005 Angela M. Brodie

Explore the following pages on Powerset:

• Angela Hartley Brodie,
• University of Maryland Greenebaum Cancer Center,
• Worcester Foundation for Biomedical Research,
• Tuberculosis treatment,
• Kettering Prize